Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**JCI MN Colloidal Iodine Cream** is a topical dermatologic colloidal iodine cream developed by **JCI Colloidal Iodine Laboratory** for dermal administration in a broad range of skin conditions, including eczema, psoriasis, pustulosis palmoplantaris, allergic dermatitis, hives, skin infections, minor skin lesions such as scratches, burns, wounds, and sunburn, as well as age-related skin changes and lip lesions. The product's active ingredient is **colloidal iodine**, described by the sponsor as a specially formulated iodine preparation intended to be used safely with less irritation than conventional iodine products. Its proposed mechanism is nonspecific and sponsor-described rather than target-defined, with claims of activating normal cells, low side-effect burden, and lack of drug resistance; no discrete molecular target has been publicly specified. The product is presented by the developer as an approved product in its pipeline materials.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on JCI MN Colloidal Iodine Cream.